BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33620575)

  • 41. The Gain-of-Function Mutation p53R248W Suppresses Cell Proliferation and Invasion of Oral Squamous Cell Carcinoma through the Down-Regulation of Keratin 17.
    Enaka M; Nakanishi M; Muragaki Y
    Am J Pathol; 2021 Mar; 191(3):555-566. PubMed ID: 33307039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas].
    Xu H; Shi XP; Tang WP; Li LX
    Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.
    Higuchi T; Orita T; Katsuya K; Yamasaki Y; Akiyama K; Li H; Yamamoto T; Saito Y; Nakamura M
    Mol Cell Biol; 2004 Sep; 24(17):7456-68. PubMed ID: 15314156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DDR2 overexpression in oral squamous cell carcinoma is associated to lymph node metastasis.
    Velmurugan BK; Chang WH; Chung CM; Yeh CM; Lee CH; Yeh KT; Lin SH
    Cancer Biomark; 2018; 22(4):747-753. PubMed ID: 29945346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
    de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
    Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phorbol ester-induced expression of airway squamous cell differentiation marker, SPRR1B, is regulated by protein kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway.
    Vuong H; Patterson T; Shapiro P; Kalvakolanu DV; Wu R; Ma WY; Dong Z; Kleeberger SR; Reddy SP
    J Biol Chem; 2000 Oct; 275(41):32250-9. PubMed ID: 10918063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors.
    Patterson T; Vuong H; Liaw YS; Wu R; Kalvakolanu DV; Reddy SP
    Oncogene; 2001 Feb; 20(5):634-44. PubMed ID: 11313996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
    Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
    Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.
    Guo Y; Ma Y; Hu X; Song R; Zhu L; Zhong M
    Cancer Biol Ther; 2018 Mar; 19(3):205-213. PubMed ID: 29281558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
    Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
    Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
    J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
    Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
    Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
    Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
    J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.